These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
4. Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment. Dinca SC; Greiner D; Weidenfeld K; Bond L; Barkan D; Jorcyk CL Breast Cancer Res; 2021 May; 23(1):56. PubMed ID: 34011405 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt/β-catenin/ZEB1 signaling. Qu J; Li M; An J; Zhao B; Zhong W; Gu Q; Cao L; Yang H; Hu C Int J Oncol; 2015 Dec; 47(6):2141-52. PubMed ID: 26459797 [TBL] [Abstract][Full Text] [Related]
10. Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer. Salvador F; Martin A; López-Menéndez C; Moreno-Bueno G; Santos V; Vázquez-Naharro A; Santamaria PG; Morales S; Dubus PR; Muinelo-Romay L; López-López R; Tung JC; Weaver VM; Portillo F; Cano A Cancer Res; 2017 Nov; 77(21):5846-5859. PubMed ID: 28720577 [TBL] [Abstract][Full Text] [Related]
11. The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers. Kundu ST; Byers LA; Peng DH; Roybal JD; Diao L; Wang J; Tong P; Creighton CJ; Gibbons DL Oncogene; 2016 Jan; 35(2):173-86. PubMed ID: 25798833 [TBL] [Abstract][Full Text] [Related]
12. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling. Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537 [No Abstract] [Full Text] [Related]
14. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer. Liu M; Zhang Y; Yang J; Zhan H; Zhou Z; Jiang Y; Shi X; Fan X; Zhang J; Luo W; Fung KA; Xu C; Bronze MS; Houchen CW; Li M Gastroenterology; 2021 Apr; 160(5):1771-1783.e1. PubMed ID: 33421513 [TBL] [Abstract][Full Text] [Related]
15. ZEB1-AS1 mediates bone metastasis through targeting miR-320b/BMPR1A axis in lung cancer. Tan N; Tang J; Chen G; Jiang W; Liu Z Clin Respir J; 2024 May; 18(5):e13770. PubMed ID: 38783645 [TBL] [Abstract][Full Text] [Related]
16. miR-1199-5p and Zeb1 function in a double-negative feedback loop potentially coordinating EMT and tumour metastasis. Diepenbruck M; Tiede S; Saxena M; Ivanek R; Kalathur RKR; Lüönd F; Meyer-Schaller N; Christofori G Nat Commun; 2017 Oct; 8(1):1168. PubMed ID: 29079737 [TBL] [Abstract][Full Text] [Related]
17. LncRNA TTN-AS1 drives invasion and migration of lung adenocarcinoma cells via modulation of miR-4677-3p/ZEB1 axis. Zhong Y; Wang J; Lv W; Xu J; Mei S; Shan A J Cell Biochem; 2019 Oct; 120(10):17131-17141. PubMed ID: 31173403 [TBL] [Abstract][Full Text] [Related]
18. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1. Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682 [TBL] [Abstract][Full Text] [Related]
19. PARP-1 induces EMT in non-small cell lung carcinoma cells via modulating the transcription factors Smad4, p65 and ZEB1. Kumar M; Jaiswal RK; Prasad R; Yadav SS; Kumar A; Yadava PK; Singh RP Life Sci; 2021 Mar; 269():118994. PubMed ID: 33417952 [TBL] [Abstract][Full Text] [Related]
20. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma. Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]